MENU
SKYE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Skye Bioscience (SKYE) Ownership - Who owns Skye Bioscience?
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
63.52M
P/E Ratio
3.57
Total Cash
59.22M
Projected Growth
N/A
Total Debt
412.11K
Revenue
N/A
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash/Share
1.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
SKYE
Capitalization
63.5M
P/E Ratio
3.57
Risk (Beta)
3.35
Dividend Yield
N/A
Total Cash
59.2M
Total Cash/Share
1.91
Total Debt
412K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
59.3M
P/B Ratio
1.07
Cash Flow
N/A
Earnings
-0.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
11.85
Current Revenue Per Employee
23699.00
Dividends Per Share - Security
N/A
EBITDA
-31.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
72.69
Revenue To Assets
-40.91
Shares Held By Institutions
47.5M
Shares Outstanding - Current
31M
Total Liabilities
5.54M
Total Volume MTD
N/A
Value
1
Gain YTD
-27.562
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information